Medicare will start covering obesity drugs for the first time. Here's what patients should know

Medicare announced it will provide coverage for obesity medications, making these drugs accessible to eligible seniors for the first time. The change applies to medications including semaglutide and tirzepatide. Novo Nordisk and Eli Lilly manufacture the primary medications expected to be covered under this policy. Seniors who are eligible will need to meet specific criteria set by Medicare to receive coverage. The decision expands treatment options for older Americans who previously could not afford these medications.

Next story